Adamas Pharmaceuticals (Adamas Pharmaceuticals) Inventory Turnover : 0.07 (As of Sep. 2021)

View and export this data going back to 2014. Start your Free Trial

What is Adamas Pharmaceuticals Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Adamas Pharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2021 was $0.58 Mil. Adamas Pharmaceuticals's Average Total Inventories for the quarter that ended in Sep. 2021 was $8.23 Mil. Adamas Pharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2021 was 0.07.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Adamas Pharmaceuticals's Days Inventory for the three months ended in Sep. 2021 was 1,304.43.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Adamas Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Sep. 2021 was 0.32.

Adamas Pharmaceuticals Inventory Turnover Historical Data

The historical data trend for Adamas Pharmaceuticals's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adamas Pharmaceuticals Inventory Turnover Chart

Adamas Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Inventory Turnover

Get a 7-Day Free Trial

0.01

0.19

0.48

0.32

Adamas Pharmaceuticals Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Inventory Turnover	Get a 7-Day Free Trial															0.08	0.08	0.05	0.07	0.07

Adamas Pharmaceuticals Inventory Turnover Calculation

Adamas Pharmaceuticals's Inventory Turnover for the fiscal year that ended in Dec. 2020 is calculated as

	Inventory Turnover (A: Dec. 2020 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2020 )	/ (	(Total Inventories (A: Dec. 2019 )	+	Total Inventories (A: Dec. 2020 ))	/	count )
=	2.038	/ (	(5.267	+	7.294)	/	2 )
=	2.038	/	6.2805
=	0.32

Adamas Pharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2021 is calculated as

	Inventory Turnover (Q: Sep. 2021 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Sep. 2021 )	/ (	(Total Inventories (Q: Jun. 2021 )	+	Total Inventories (Q: Sep. 2021 ))	/	count )
=	0.576	/ (	(7.788	+	8.68)	/	2 )
=	0.576	/	8.234
=	0.07

Adamas Pharmaceuticals (NAS:ADMS) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Adamas Pharmaceuticals's Days Inventory for the three months ended in Sep. 2021 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2021 )	/	Cost of Goods Sold (Q: Sep. 2021 )	*	Days in Period
	=	8.234	/	0.576	*	365 / 4
	=	1,304.43

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Adamas Pharmaceuticals's Inventory to Revenue for the quarter that ended in Sep. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Sep. 2021 )	/	Revenue (Q: Sep. 2021 )
	=	8.234	/	25.896
	=	0.32

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Adamas Pharmaceuticals Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Adamas Pharmaceuticals's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Adamas Pharmaceuticals (Adamas Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adamas Pharmaceuticals Inc (NAS:ADMS) » Definitions » Inventory Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 Powell Street, Suite 1000, Emeryville, CA, USA, 94608

Website

http://www.adamaspharma.com

Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.

Executives

Vijay Shreedhar	officer: Chief Commercial Officer	C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL STREET, SUITE 1000 EMERYVILLE CA 94608
Christopher B Prentiss	officer: Chief Financial Officer	1900 POWELL STREET SUITE 750 EMERYVILLE CA 94608
Anna Richo	director	AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
David L Mahoney	director	SYMANTEC CORPORATION, 20330 STEVENS CREEK BLVD., CUPERTINO CA 95014
Mardi Dier	director	C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
William W. Ericson	director, 10 percent owner	777 MARINERS ISLAND BOULEVARD, SUITE 550, SAN MATEO CA 94404
John A Macphee	director	C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Ivan M Lieberburg	director	11682 EL CAMINO REAL, SUITE 320, SAN DIEGO CA 92130
Michael Bigham	director	890 WINTER STREET, WALTHAM MA 02451
Martha J Demski	director	7770 REGENTS ROAD SUITE 113-505, SAN DIEGO CA 92122
Neil F. Mcfarlane	officer: Chief Executive Officer	C/O RETROPHIN, INC., 12255 EL CAMINO REAL, SUITE 250, SAN DIEGO CA 92130
Alfred G Merriweather	officer: Chief Financial Officer
Jennifer J Rhodes	officer: CBO, GC & Compliance Officer	C/O ADAMAS PHARMACEUTICALS INC., 1900 POWELL ST., SUITE 750, EMERYVILLE CA 94608
Gregory T Went	director, officer: Chief Executive Officer	C/O ADAMAS PHARMACEUTICALS, INC. 2200 POWELL ST, STE 220 EMERYVILLE CA 94608
Rajiv Patni	officer: Chief Medical Officer	C/O OCERA THERAPEUTICS, INC., 525 UNIVERSITY AVENUE, SUITE 610, PALO ALTO CA 94301